Cargando…
bub1 as a potential oncogene and a prognostic biomarker for neuroblastoma
BACKGROUND: Neuroblastoma is the most common malignant extracranial tumor for children. Molecular mechanisms underpinning the pathogenesis of this disease are yet to be fully clarified. This study aimed to identify a novel oncogene that could be used as a biomarker informing the prognosis of neurobl...
Autores principales: | Song, Jingjing, Ni, Chao, Dong, Xubin, Sheng, Chenang, Qu, Yue, Zhu, Libin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552328/ https://www.ncbi.nlm.nih.gov/pubmed/36237324 http://dx.doi.org/10.3389/fonc.2022.988415 |
Ejemplares similares
-
L Antigen Family Member 3 Serves as a Prognostic Biomarker for the Clinical Outcome and Immune Infiltration in Skin Cutaneous Melanoma
por: Song, Jingjing, et al.
Publicado: (2021) -
Exploration of the Prognostic and Immunotherapeutic Value of B and T Lymphocyte Attenuator in Skin Cutaneous Melanoma
por: Dong, Xubin, et al.
Publicado: (2021) -
Evaluation of Oncogene NUP37 as a Potential Novel Biomarker in Breast Cancer
por: Li, Kangdi, et al.
Publicado: (2021) -
Pan-cancer analysis identified OAS1 as a potential prognostic biomarker for multiple tumor types
por: Jiang, Shan, et al.
Publicado: (2023) -
Development and Validation of an RNA-Seq-Based Prognostic Signature in Neuroblastoma
por: Zhou, Jian-Guo, et al.
Publicado: (2019)